2021
DOI: 10.12968/coan.2021.0073
|View full text |Cite
|
Sign up to set email alerts
|

Vatinoxan – a new development for the clinical use of α2-adrenoceptor agonists in dogs: part 2

Abstract: The first article in this two part series explored the pharmacodynamics of vatinoxan as a peripherally acting α2 adrenoceptor agonist, and in this installment the pharmacokinetics of vatinoxan and its effect on coadministered drugs are explored.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 15 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?